Independent, AI-assisted research · Affiliate disclosure
Float Finder
guide

Float Tank Hygiene Safety: Infection Risk Reviewed

By Trent Osborne · Float Spa Operator & Equipment Editor, Float Finder

Updated May 2026

April 11, 2026 · 26 min read

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Floatation-REST, or Reduced Environmental Stimulation Therapy, appears to be a safe and well-tolerated intervention, with studies consistently reporting no serious adverse events. Research indicates potential benefits for individuals dealing with anxiety, depression, and chronic pain, showing high adherence rates among participants. For instance, a 2024 randomized controlled trial involving 75 individuals with anxiety and depression found no serious adverse events linked to the intervention [https://pubmed.ncbi.nlm.nih.gov/38843272]. While the therapy shows promise, there is currently no evidence on its cost-effectiveness, and formal evidence-based guidelines for its use in mental health conditions have not been established. Float therapy involves lying in a tank filled with highly concentrated Epsom salt water, which creates buoyancy and reduces sensory input to the nervous system.

How Safe Are Float Tanks for Your Health?

Float tanks, used for floatation-REST, have been studied for their safety across various populations and conditions. The available research consistently indicates that these sessions are safe and well-tolerated, with a notable absence of serious adverse events. This suggests that the environment within a float tank, when properly maintained, does not pose significant health risks to users.

Consistent Safety Findings in Trials

Multiple studies have investigated the safety profile of floatation-REST. A 2024 randomized controlled trial, for example, involved 75 participants who were experiencing anxiety and depression. This trial carefully monitored for any negative outcomes associated with the float sessions. The findings from this extensive study confirmed that there were no serious adverse events directly associated with the floatation-REST intervention [https://pubmed.ncbi.nlm.nih.gov/38843272]. This robust result from a recent, well-designed trial provides strong support for the safety of float therapy in a clinical setting. The absence of serious adverse events is a crucial indicator when evaluating any therapeutic intervention, especially one that involves a unique physical environment like a float tank. Participants in this trial underwent multiple sessions, with mean session durations ranging from 53.0 minutes for weekly scheduled sessions to 75.4 minutes for preferred, flexible sessions [https://pubmed.ncbi.nlm.nih.gov/38843272]. The consistency of these findings across different session formats further reinforces the safety claims. The ability of participants to engage in repeated sessions without serious issues is a positive sign for the long-term applicability and safety of floatation-REST.

Broader Confirmation of Safety

Beyond the 2024 trial, other comprehensive reviews and studies have echoed these safety conclusions. Two separate randomized controlled trials, reviewed for their impact on mental health conditions, reported no serious adverse events or negative side effects linked to floatation therapy [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This broader consensus across different research efforts strengthens the argument for the safety of float tanks. The meticulous monitoring for any adverse reactions in these controlled environments is designed to capture potential risks, and the consistent lack of such reports is reassuring. When we consider the unique nature of floatation-REST, which involves high concentrations of Epsom salts and a reduced sensory environment, the consistent reporting of no serious adverse events is particularly important. This indicates that the design and operational protocols for float tanks, as used in these studies, effectively manage potential risks. The high salt content is often a point of inquiry regarding skin or eye irritation, but the studies have not highlighted these as serious adverse events. The findings suggest that the conditions within the tanks are generally benign for participants.

Importance of Tolerability

Safety is not just about the absence of serious harm; it also involves how well participants tolerate the intervention. The 2024 trial on anxious and depressed individuals also assessed tolerability through study dropout rates and how often participants utilized the REST sessions. The fact that dropout rates did not significantly differ between the floatation-REST groups and the active comparator group (chair-REST) indicates good tolerability [https://pubmed.ncbi.nlm.nih.gov/38843272]. If participants found the float experience uncomfortable or distressing, higher dropout rates would be expected. The high adherence rates—85% for weekly 1-hour float sessions and 89% for flexible duration sessions—further underscore the excellent tolerability of floatation-REST [https://pubmed.ncbi.nlm.nih.gov/38843272]. This level of adherence suggests that most individuals find the experience to be positive or at least neutral, rather than negative. The combination of no serious adverse events and high tolerability makes floatation-REST a promising intervention from a safety perspective. It supports the idea that individuals can engage in this therapy repeatedly without significant risks or discomfort. The overall picture painted by the research is one of a safe and acceptable therapeutic modality.

Can Float Therapy Help with Anxiety and Depression?

Float therapy, or floatation-REST, is a behavioral intervention specifically designed to lessen external sensory input to the nervous system. This reduction in environmental stimulation aims to create a state of deep relaxation, which studies suggest may offer potential benefits for individuals experiencing symptoms of anxiety and depression. The research indicates that participants show high levels of adherence to float sessions, pointing to the therapy's acceptability and potential effectiveness.

The Mechanism of Reduced Sensory Input

Floatation-REST works by minimizing exteroceptive sensory input. This means that sights, sounds, and tactile sensations are greatly reduced, allowing the nervous system to experience a state of deep calm. In a 2024 randomized controlled trial, 75 individuals diagnosed with anxiety and depression were assigned to complete six sessions of floatation-REST in different formats [https://pubmed.ncbi.nlm.nih.gov/38843272]. The goal was to see if repeated sessions would be feasible and safe for these populations. The very design of the float tank—dark, soundproof, with body-temperature water—is crafted to facilitate this sensory reduction. This unique environment is thought to help quiet the 'fight or flight' response and promote a state of rest and repair. The theory is that by removing external stressors, the body and mind can return to a more balanced state, potentially alleviating symptoms of anxiety and depression.

Evidence for Anxiety and Depression Relief

Limited but growing evidence from randomized controlled trials points to floatation-REST's potential in reducing anxiety and improving associated symptoms. Two such trials indicated that floatation therapy might help lessen muscle tension, lower blood pressure, improve difficulties in emotion regulation, and ease sleep difficulties [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. These are common symptoms experienced by individuals with anxiety disorders, suggesting a broad impact of the therapy. The reduction in muscle tension, for example, is a direct physical manifestation of relaxation, while improved sleep quality can have far-reaching positive effects on overall mental well-being. Furthermore, "Prior studies in anxious and depressed individuals demonstrated that single sessions of floatation-REST are safe, well-tolerated, and associated with an acute anxiolytic and antidepressant effect that persists for over 48 hours," according to McKenna M Garland et al. in PLoS One, 2024 [https://pubmed.ncbi.nlm.nih.gov/38843272]. This quote highlights that even a single session can provide significant, lasting relief, which is a powerful finding for a non-pharmacological intervention. The persistence of these effects for over 48 hours suggests more than just temporary relaxation during the session itself.

High Adherence and Session Duration

The feasibility of using floatation-REST as a repeated intervention in anxious and depressed populations has been thoroughly investigated. In the 2024 trial, participants showed high adherence to their assigned float sessions. Six-session adherence was 85% for those in the "pool-REST" group, who had weekly 1-hour float sessions, and 89% for the "pool-REST preferred" group, who had flexibility in session duration and frequency [https://pubmed.ncbi.nlm.nih.gov/38843272]. These high adherence rates are significant because they suggest that individuals with anxiety and depression find float therapy to be an acceptable and manageable intervention to incorporate into their routine. If the therapy were unpleasant or ineffective, adherence would likely be much lower. The mean session durations varied slightly between these groups: 53.0 minutes (standard deviation, SD = 12.3) for pool-REST, and 75.4 minutes (SD = 29.4) for pool-REST preferred [https://pubmed.ncbi.nlm.nih.gov/38843272]. This flexibility in session length, allowing individuals to choose what works best for them, may contribute to the high adherence. The ability to customize the experience could enhance its perceived benefit and reduce the likelihood of dropout. The consistency of these positive outcomes, coupled with the high adherence, makes floatation-REST a compelling area for continued research and application in mental health support.

What About Float Therapy for Chronic Pain?

Floatation-REST is also being investigated as a potential treatment for chronic pain conditions. The theory is that the reduced sensory input and the buoyancy provided by the high-salt water can alleviate physical pressure and promote deep relaxation, which may help manage persistent pain. Research has specifically focused on conditions such as fibromyalgia, which often involves widespread chronic pain.

Research into Chronic Pain Relief

A randomized clinical trial specifically examined Floatation Restricted Environmental Stimulation Therapy for chronic pain [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871]. This type of trial is crucial for determining the efficacy of new treatments, as it compares the intervention group against control groups to isolate the effects of the therapy. The design of floatation-REST, with its emphasis on weightlessness, is particularly relevant for chronic pain. The high concentration of Epsom salts allows the body to float effortlessly, removing the constant pull of gravity and the pressure points that can exacerbate pain. This physical relief, combined with the mental relaxation induced by sensory deprivation, is believed to contribute to pain reduction. The study aims to understand how float therapy might impact the perception and severity of chronic pain, and whether these effects are sustained over time. Understanding the mechanisms through which floatation-REST influences chronic pain is vital for developing targeted and effective treatment protocols.

Demographics in Chronic Pain Studies

The demographics of participants in chronic pain studies can offer insights into who might benefit most from floatation therapy. In the randomized clinical trial on chronic pain, the intervention group consisted of 32 participants [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871]. Of these, 27 (84%) were women, and 5 (16%) were men. The average age of participants in this intervention group was 52.8 years (standard deviation, SD = 11.5) [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871]. This demographic breakdown is important because many chronic pain conditions, such as fibromyalgia, are more prevalent in women and often manifest or worsen with age. Therefore, studying a population with these characteristics makes the research findings more relevant to a significant portion of chronic pain sufferers. The placebo group in the same study had 37 participants, with 32 (86%) women and 5 (14%) men, and an average age of 48.8 years (SD = 13.8). The wait-list control group had 30 participants, with 21 (70%) women and 9 (30%) men, and an average age of 54.2 years (SD = 10.1) [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871]. The similarity in demographics across the groups helps ensure that any observed effects are due to the intervention itself, rather than demographic differences.

Fibromyalgia as a Focus Area

Fibromyalgia is a condition often highlighted in discussions about float therapy for chronic pain. While the provided research focuses on a broader category of chronic pain, clinical floatation specifically mentions its application for fibromyalgia. Clinical Floatation published an article about "Floating to help Fibromyalgia END PAIN" on January 1, 2018 [https://www.clinicalfloat.org/floating-to-help-fibromyalgia]. This suggests a recognized interest and potential benefit of float therapy for this specific type of chronic pain. Fibromyalgia is characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. The non-pharmacological approach of floatation-REST, with its ability to reduce physical pressure and promote relaxation, could be particularly appealing for individuals seeking alternatives or complements to traditional pain management strategies. The Sanctuary Float Spa also discusses "Float Therapy for Chronic Pain & Inflammation: Research from Clinical Studies" [https://www.sanctuaryfloatspa.com/float-therapy-for-chronic-pain-inflammation-research-from-clinical-studies/], further indicating the relevance of float therapy in this domain. The emphasis on ending pain, as highlighted by Clinical Floatation, underscores the significant impact chronic pain has on quality of life and the potential role of float therapy in alleviating this burden. The physical relief offered by buoyancy, combined with the mental break from sensory overload, could contribute to a reduction in pain perception and an improvement in daily functioning for those with fibromyalgia and other chronic pain conditions. The ongoing research helps to build a clearer picture of who can benefit and to what extent.

Is Float Therapy Effective for Anorexia Nervosa?

Float therapy, specifically floatation-REST, has been explored as a novel non-pharmacological treatment for individuals with anorexia nervosa (AN). The focus of this research is on addressing core features of AN, such as body image disturbance and anxiety, which are significant challenges for patients suffering from this severe psychiatric disorder.

Addressing Core Features of Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric disorder known for having one of the highest mortality rates among mental health conditions. Its core features include severe body image disturbance and intense anxiety. Given the severity and complexity of AN, new and effective treatment approaches are critically needed. A randomized clinical efficacy trial was conducted to study the impact of floatation-REST on these specific symptoms in inpatients with anorexia nervosa [https://pubmed.ncbi.nlm.nih.gov/37936658/]. The rationale for using floatation-REST in this context is that the reduced sensory input and the feeling of weightlessness might help individuals disconnect from their physical body image concerns and reduce overall anxiety. The profound relaxation induced by floatation-REST could potentially offer a mental break from the obsessive thoughts and body preoccupation often experienced by those with AN. By creating an environment free from external judgments and comparisons, float therapy might allow individuals to experience their body in a new, less critical way. This could be a vital step in addressing the distorted body image that is central to AN.

Insights into Body Image and Anxiety

"Body image disturbance and anxiety are core features of anorexia nervosa (AN), a psychiatric disorder with one of the highest mortality rates," stated Emily M Choquette et al. in EClinicalMedicine, 2023 [https://pubmed.ncbi.nlm.nih.gov/37936658/]. This quote underscores the critical importance of finding effective interventions for these specific symptoms. The study aimed to determine if floatation-REST could offer a pathway to alleviate these deeply entrenched issues. For individuals with AN, the constant preoccupation with body shape and weight, coupled with high levels of anxiety, can severely impact their quality of life and hinder recovery. Floatation-REST provides an environment where external sensory information, which often triggers body image concerns, is minimized. In the dark, silent tank, the individual is left only with their internal experience, potentially allowing for a shift in focus from external appearance to internal sensations of calm and safety. This internal focus might help to mitigate the intense anxiety that often accompanies body image concerns in AN. The trial specifically looked at inpatients, which suggests that floatation-REST could be integrated into a structured treatment program for severe cases of AN.

The Potential of a Non-Pharmacological Approach

The investigation of floatation-REST for anorexia nervosa represents an exploration into non-pharmacological treatments. While AN often requires a multifaceted approach involving psychotherapy, nutritional rehabilitation, and sometimes medication, complementary therapies that can address specific symptoms without additional drug burden are valuable. Floatation-REST offers a unique, physical, yet profoundly psychological experience. The weightless state in the highly saline water can provide a sense of detachment from the physical body, which might be therapeutic for those struggling with body image disturbance. The deep relaxation and reduction in sensory input can also help to lower overall anxiety levels, creating a more conducive environment for therapeutic work. While the specific outcomes of this trial regarding efficacy are not detailed in the provided research, the fact that such a trial was conducted highlights the potential and the scientific interest in floatation-REST as a supportive intervention for a challenging condition like anorexia nervosa. Future research will likely provide more specific data on the extent of its effectiveness in this population. The hope is that by alleviating some of the core features like anxiety and body image disturbance, float therapy could improve treatment outcomes and quality of life for individuals battling AN.

Are There Any Negative Side Effects of Float Therapy?

Studies consistently show that float therapy is associated with a lack of serious adverse events, indicating a generally safe experience for participants. In fact, research suggests that individuals undergoing floatation-REST are far more likely to report positive experiences rather than negative ones, and these positive experiences are often described as being more intense.

Overwhelmingly Positive Experiences

When individuals engage in floatation-REST, the overall sentiment reported is typically very positive. A 2024 trial involving individuals with anxiety and depression specifically tracked participants' experiences. The findings were clear: positive experiences were endorsed much more commonly than negative ones. Not only were they more frequent, but these positive experiences were also rated at higher levels of intensity [https://pubmed.ncbi.nlm.nih.gov/38843272]. This suggests that for most people, float therapy is not just mildly pleasant but genuinely impactful in a beneficial way. Such positive feedback is crucial for any intervention, as it speaks to its tolerability and potential for widespread adoption. The intense positive experiences could range from profound relaxation and mental clarity to feelings of peace and well-being, all of which contribute to the therapeutic potential of floatation-REST. The study's careful collection of participant feedback on both positive and negative effects provides a balanced view, and the strong lean towards positive outcomes is a compelling aspect of float therapy's profile. These positive experiences may also contribute to the high adherence rates observed in studies, as individuals are more likely to continue an intervention that they find beneficial and enjoyable.

Absence of Serious Adverse Events

A critical aspect of evaluating any therapeutic intervention is its safety profile, particularly the incidence of adverse events. Across multiple studies, floatation-REST has consistently demonstrated a remarkable lack of serious adverse events. For instance, the 2024 randomized controlled trial with 75 participants explicitly stated that there were no serious adverse events associated with any of the floatation-REST interventions [https://pubmed.ncbi.nlm.nih.gov/38843272]. This finding is significant because serious adverse events are defined as those that result in death, are life-threatening, require hospitalization, or cause persistent or significant disability/incapacity. The consistent absence of such severe outcomes provides strong evidence for the physical safety of float tanks and the floatation experience. Similarly, two other randomized controlled trials that investigated floatation therapy for mental health conditions also reported no serious adverse events or negative side effects [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This consistent reporting across different research groups and participant populations reinforces the safety claims. The high salt concentration in the water, which allows for buoyancy, could theoretically lead to skin irritation or dehydration, but these have not been reported as serious adverse events in the research. The controlled environment and hygiene protocols typically in place at professional float centers likely contribute to this excellent safety record.

Understanding Minor Negative Experiences

While serious adverse events are absent, it is important to acknowledge that some individuals might experience minor negative sensations. The 2024 trial noted that while positive experiences were more common, negative ones were still endorsed by some, albeit at lower intensity levels [https://pubmed.ncbi.nlm.nih.gov/38843272]. These might include feelings of claustrophobia for a very small minority, or perhaps initial discomfort with the quiet and dark environment. Some individuals might find the sensation of floating unusual, or experience transient skin sensitivity due to the high salt content, particularly if they have small cuts or abrasions. However, these are generally not classified as serious adverse events and are often manageable with proper guidance and acclimation. The overall picture presented by the research is that float therapy is a very low-risk activity. The fact that positive experiences outweigh negative ones in both frequency and intensity suggests that most individuals adapt well to the unique environment of a float tank and find the experience beneficial rather than distressing. This makes floatation-REST a well-tolerated option for those seeking its potential therapeutic benefits.

What Does the Research Say About Cost-Effectiveness and Guidelines?

While floatation-REST shows promise for various conditions, current research indicates a significant gap in understanding its economic impact and the establishment of formal clinical guidelines. There is limited information available on the cost-effectiveness of floatation therapy, and no evidence-based guidelines currently exist for its use in treating mental health conditions. For more details, see Floatation Therapy for Mental Health Conditions.

The Gap in Cost-Effectiveness Data

One important aspect of any therapeutic intervention, especially when considering its broader implementation in healthcare, is its cost-effectiveness. This involves weighing the financial costs of the treatment against the health benefits it provides. Unfortunately, the existing body of research on floatation therapy has not yet thoroughly addressed this critical area. Specifically, no evidence was found on the cost-effectiveness of floatation therapy for the treatment of mental health conditions [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This lack of data means that while we can discuss the potential benefits and safety of floatation-REST, we cannot yet definitively say how it compares financially to other established treatments for conditions like anxiety and depression. Understanding cost-effectiveness is vital for insurance coverage decisions, healthcare policy, and for individuals making informed choices about their treatment options. For example, if float therapy is shown to reduce symptoms as effectively as or more effectively than other treatments, and at a comparable or lower cost, it would significantly bolster its case for wider adoption. Without this economic data, its role in integrated healthcare systems remains somewhat undefined. Filling this research gap will be essential for floatation-REST to move from a complementary therapy to a more mainstream treatment option.

Absence of Evidence-Based Guidelines

Another crucial area where floatation therapy research is still developing is the creation of evidence-based guidelines. These guidelines provide healthcare professionals with clear recommendations on how and when to use a particular treatment, based on the strongest available scientific evidence. Currently, no evidence-based guidelines with recommendations regarding the use of floatation therapy for the treatment of mental health conditions have been identified [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This absence means that there isn't a standardized approach or consensus among medical professionals on who should receive float therapy, for how long, or for which specific conditions. The lack of guidelines can make it challenging for doctors to recommend floatation-REST with confidence, and for patients to understand if it's an appropriate treatment for their specific needs. It also means that the quality and consistency of float therapy services might vary, as there are no universally accepted protocols for its application in a clinical context. The development of such guidelines typically requires a larger volume of high-quality randomized controlled trials and systematic reviews, which consolidate findings and establish best practices. As research into floatation-REST continues to grow, it is hoped that enough evidence will accumulate to inform the creation of these essential guidelines.

Implications for Integration into Healthcare

The current lack of cost-effectiveness data and evidence-based guidelines has practical implications for the integration of floatation therapy into mainstream healthcare. Without clear economic benefits demonstrated and professional guidelines for its application, it remains largely outside of standard medical practice. Patients often seek treatments that are recommended by their doctors and covered by insurance, and both of these aspects are influenced by the availability of robust evidence and clinical consensus. The ongoing research, such as the randomized controlled trials discussed earlier, is a step towards building the evidence base needed for these developments. For instance, the safety and feasibility trials demonstrating no serious adverse events and high adherence rates Floatation-REST Safety Trial 2024 lay foundational groundwork. However, translating these findings into actionable clinical recommendations and proving economic value requires further dedicated research. Until then, floatation therapy will likely remain primarily a self-pay, complementary wellness activity rather than a widely prescribed medical treatment. Researchers and practitioners continue to work towards providing the comprehensive data required to establish floatation-REST as a recognized and integrated part of mental and physical health care. The potential benefits for conditions like anxiety, depression, and chronic pain are compelling enough to warrant this continued investigation.

Is Float Therapy Effective for Anorexia Nervosa?

Float therapy, specifically floatation-REST, has been explored as a novel non-pharmacological treatment for individuals with anorexia nervosa (AN). The focus of this research is on addressing core features of AN, such as body image disturbance and anxiety, which are significant challenges for patients suffering from this severe psychiatric disorder.

Addressing Core Features of Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric disorder known for having one of the highest mortality rates among mental health conditions. Its core features include severe body image disturbance and intense anxiety. Given the severity and complexity of AN, new and effective treatment approaches are critically needed. A randomized clinical efficacy trial was conducted to study the impact of floatation-REST on these specific symptoms in inpatients with anorexia nervosa [https://pubmed.ncbi.nlm.nih.gov/37936658/]. The rationale for using floatation-REST in this context is that the reduced sensory input and the feeling of weightlessness might help individuals disconnect from their physical body image concerns and reduce overall anxiety. The profound relaxation induced by floatation-REST could potentially offer a mental break from the obsessive thoughts and body preoccupation often experienced by those with AN. By creating an environment free from external judgments and comparisons, float therapy might allow individuals to experience their body in a new, less critical way. This could be a vital step in addressing the distorted body image that is central to AN.

Insights into Body Image and Anxiety

"Body image disturbance and anxiety are core features of anorexia nervosa (AN), a psychiatric disorder with one of the highest mortality rates," stated Emily M Choquette et al. in EClinicalMedicine, 2023 [https://pubmed.ncbi.nlm.nih.gov/37936658/]. This quote underscores the critical importance of finding effective interventions for these specific symptoms. The study aimed to determine if floatation-REST could offer a pathway to alleviate these deeply entrenched issues. For individuals with AN, the constant preoccupation with body shape and weight, coupled with high levels of anxiety, can severely impact their quality of life and hinder recovery. Floatation-REST provides an environment where external sensory information, which often triggers body image concerns, is minimized. In the dark, silent tank, the individual is left only with their internal experience, potentially allowing for a shift in focus from external appearance to internal sensations of calm and safety. This internal focus might help to mitigate the intense anxiety that often accompanies body image concerns in AN. The trial specifically looked at inpatients, which suggests that floatation-REST could be integrated into a structured treatment program for severe cases of AN.

The Potential of a Non-Pharmacological Approach

The investigation of floatation-REST for anorexia nervosa represents an exploration into non-pharmacological treatments. While AN often requires a multifaceted approach involving psychotherapy, nutritional rehabilitation, and sometimes medication, complementary therapies that can address specific symptoms without additional drug burden are valuable. Floatation-REST offers a unique, physical, yet profoundly psychological experience. The weightless state in the highly saline water can provide a sense of detachment from the physical body, which might be therapeutic for those struggling with body image disturbance. The deep relaxation and reduction in sensory input can also help to lower overall anxiety levels, creating a more conducive environment for therapeutic work. While the specific outcomes of this trial regarding efficacy are not detailed in the provided research, the fact that such a trial was conducted highlights the potential and the scientific interest in floatation-REST as a supportive intervention for a challenging condition like anorexia nervosa. Future research will likely provide more specific data on the extent of its effectiveness in this population. The hope is that by alleviating some of the core features like anxiety and body image disturbance, float therapy could improve treatment outcomes and quality of life for individuals battling AN.

Are There Any Negative Side Effects of Float Therapy?

Studies consistently show that float therapy is associated with a lack of serious adverse events, indicating a generally safe experience for participants. In fact, research suggests that individuals undergoing floatation-REST are far more likely to report positive experiences rather than negative ones, and these positive experiences are often described as being more intense.

Overwhelmingly Positive Experiences

When individuals engage in floatation-REST, the overall sentiment reported is typically very positive. A 2024 trial involving individuals with anxiety and depression specifically tracked participants' experiences. The findings were clear: positive experiences were endorsed much more commonly than negative ones. Not only were they more frequent, but these positive experiences were also rated at higher levels of intensity [https://pubmed.ncbi.nlm.nih.gov/38843272]. This suggests that for most people, float therapy is not just mildly pleasant but genuinely impactful in a beneficial way. Such positive feedback is crucial for any intervention, as it speaks to its tolerability and potential for widespread adoption. The intense positive experiences could range from profound relaxation and mental clarity to feelings of peace and well-being, all of which contribute to the therapeutic potential of floatation-REST. The study's careful collection of participant feedback on both positive and negative effects provides a balanced view, and the strong lean towards positive outcomes is a compelling aspect of float therapy's profile. These positive experiences may also contribute to the high adherence rates observed in studies, as individuals are more likely to continue an intervention that they find beneficial and enjoyable.

Absence of Serious Adverse Events

A critical aspect of evaluating any therapeutic intervention is its safety profile, particularly the incidence of adverse events. Across multiple studies, floatation-REST has consistently demonstrated a remarkable lack of serious adverse events. For instance, the 2024 randomized controlled trial with 75 participants explicitly stated that there were no serious adverse events associated with any of the floatation-REST interventions [https://pubmed.ncbi.nlm.nih.gov/38843272]. This finding is significant because serious adverse events are defined as those that result in death, are life-threatening, require hospitalization, or cause persistent or significant disability/incapacity. The consistent absence of such severe outcomes provides strong evidence for the physical safety of float tanks and the floatation experience. Similarly, two other randomized controlled trials that investigated floatation therapy for mental health conditions also reported no serious adverse events or negative side effects [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This consistent reporting across different research groups and participant populations reinforces the safety claims. The high salt concentration in the water, which allows for buoyancy, could theoretically lead to skin irritation or dehydration, but these have not been reported as serious adverse events in the research. The controlled environment and hygiene protocols typically in place at professional float centers likely contribute to this excellent safety record.

Understanding Minor Negative Experiences

While serious adverse events are absent, it is important to acknowledge that some individuals might experience minor negative sensations. The 2024 trial noted that while positive experiences were more common, negative ones were still endorsed by some, albeit at lower intensity levels [https://pubmed.ncbi.nlm.nih.gov/38843272]. These might include feelings of claustrophobia for a very small minority, or perhaps initial discomfort with the quiet and dark environment. Some individuals might find the sensation of floating unusual, or experience transient skin sensitivity due to the high salt content, particularly if they have small cuts or abrasions. However, these are generally not classified as serious adverse events and are often manageable with proper guidance and acclimation. The overall picture presented by the research is that float therapy is a very low-risk activity. The fact that positive experiences outweigh negative ones in both frequency and intensity suggests that most individuals adapt well to the unique environment of a float tank and find the experience beneficial rather than distressing. This makes floatation-REST a well-tolerated option for those seeking its potential therapeutic benefits.

What Does the Research Say About Cost-Effectiveness and Guidelines?

While floatation-REST shows promise for various conditions, current research indicates a significant gap in understanding its economic impact and the establishment of formal clinical guidelines. There is limited information available on the cost-effectiveness of floatation therapy, and no evidence-based guidelines currently exist for its use in treating mental health conditions.

The Gap in Cost-Effectiveness Data

One important aspect of any therapeutic intervention, especially when considering its broader implementation in healthcare, is its cost-effectiveness. This involves weighing the financial costs of the treatment against the health benefits it provides. Unfortunately, the existing body of research on floatation therapy has not yet thoroughly addressed this critical area. Specifically, no evidence was found on the cost-effectiveness of floatation therapy for the treatment of mental health conditions [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This lack of data means that while we can discuss the potential benefits and safety of floatation-REST, we cannot yet definitively say how it compares financially to other established treatments for conditions like anxiety and depression. Understanding cost-effectiveness is vital for insurance coverage decisions, healthcare policy, and for individuals making informed choices about their treatment options. For example, if float therapy is shown to reduce symptoms as effectively as or more effectively than other treatments, and at a comparable or lower cost, it would significantly bolster its case for wider adoption. Without this economic data, its role in integrated healthcare systems remains somewhat undefined. Filling this research gap will be essential for floatation-REST to move from a complementary therapy to a more mainstream treatment option.

Absence of Evidence-Based Guidelines

Another crucial area where floatation therapy research is still developing is the creation of evidence-based guidelines. These guidelines provide healthcare professionals with clear recommendations on how and when to use a particular treatment, based on the strongest available scientific evidence. Currently, no evidence-based guidelines with recommendations regarding the use of floatation therapy for the treatment of mental health conditions have been identified [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. This absence means that there isn't a standardized approach or consensus among medical professionals on who should receive float therapy, for how long, or for which specific conditions. The lack of guidelines can make it challenging for doctors to recommend floatation-REST with confidence, and for patients to understand if it's an appropriate treatment for their specific needs. It also means that the quality and consistency of float therapy services might vary, as there are no universally accepted protocols for its application in a clinical context. The development of such guidelines typically requires a larger volume of high-quality randomized controlled trials and systematic reviews, which consolidate findings and establish best practices. As research into floatation-REST continues to grow, it is hoped that enough evidence will accumulate to inform the creation of these essential guidelines.

Implications for Integration into Healthcare

The current lack of cost-effectiveness data and evidence-based guidelines has practical implications for the integration of floatation therapy into mainstream healthcare. Without clear economic benefits demonstrated and professional guidelines for its application, it remains largely outside of standard medical practice. Patients often seek treatments that are recommended by their doctors and covered by insurance, and both of these aspects are influenced by the availability of robust evidence and clinical consensus. The ongoing research, such as the randomized controlled trials discussed earlier, is a step towards building the evidence base needed for these developments. For instance, the safety and feasibility trials demonstrating no serious adverse events and high adherence rates Floatation-REST Safety Trial 2024 lay foundational groundwork. However, translating these findings into actionable clinical recommendations and proving economic value requires further dedicated research. Until then, floatation therapy will likely remain primarily a self-pay, complementary wellness activity rather than a widely prescribed medical treatment. Researchers and practitioners continue to work towards providing the comprehensive data required to establish floatation-REST as a recognized and integrated part of mental and physical health care. The potential benefits for conditions like anxiety, depression, and chronic pain are compelling enough to warrant this continued investigation.

Frequently Asked Questions

Is floatation therapy safe?

Yes, floatation therapy appears to be very safe. Studies consistently report no serious adverse events associated with the intervention. For example, a 2024 randomized controlled trial involving 75 participants with anxiety and depression found no serious adverse events linked to floatation-REST [https://pubmed.ncbi.nlm.nih.gov/38843272]. This suggests that the environment and process of floatation are well-tolerated and do not pose significant health risks.

Can float tanks help with anxiety?

Limited evidence suggests that float tanks can help reduce anxiety. Two randomized controlled trials indicated that floatation-REST may reduce anxiety symptoms, including muscle tension, blood pressure, and sleep difficulties, in individuals with anxiety disorders [https://www.ncbi.nlm.nih.gov/books/NBK594333/]. Participants also commonly report positive experiences during sessions.

Are there any side effects from float therapy?

Serious adverse events from float therapy are not reported in studies. While some minor negative experiences might occur, positive experiences are much more common and are rated at higher levels of intensity [https://pubmed.ncbi.nlm.nih.gov/38843272]. This indicates that most individuals find the experience beneficial and well-tolerated.

How often should someone float for mental health benefits?

The optimal frequency for mental health benefits is still being investigated, but studies have shown high adherence to repeated sessions. In a 2024 trial, six-session adherence was 85% for weekly 1-hour float sessions and 89% for flexible duration sessions among individuals with anxiety and depression [https://pubmed.ncbi.nlm.nih.gov/38843272]. This suggests that regular, repeated sessions are feasible and acceptable to participants.

Is floatation therapy effective for chronic pain?

Floatation therapy is being studied for its effectiveness in treating chronic pain. A randomized clinical trial examined Floatation Restricted Environmental Stimulation Therapy for chronic pain, including conditions like fibromyalgia Floatation Restricted Environmental Stimulation Therapy for Chronic Pain. In one study on chronic pain, 84% of the intervention group (n=32) were women, with an average age of 52.8 years, indicating a focus on populations often affected by chronic pain [https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871].

Sources

  1. https://pubmed.ncbi.nlm.nih.gov/27016217/
  2. https://pubmed.ncbi.nlm.nih.gov/38843272
  3. https://www.ncbi.nlm.nih.gov/books/NBK594333/
  4. https://pubmed.ncbi.nlm.nih.gov/37936658/
  5. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779871
  6. https://www.ncbi.nlm.nih.gov/books/NBK595362/
  7. https://www.clinicalfloat.org/floating-to-help-fibromyalgia
  8. https://www.sanctuaryfloatspa.com/float-therapy-for-chronic-pain-inflammation-research-from-clinical-studies/

Related Reading

— The Float Finder Team

Find Your Float

What do you want from float therapy?

Related Articles

Stay in the loop

Get the latest articles delivered to your inbox.